https://orcid.org/0000-0002-5988-1469
References
- Chang JH, Mccluskey PJ, Wakefield D. Acute anterior uveitis and HLA‐B27. Surv Ophthalmol 2005; 50: 364–388.
- Rudwaleit M, van der Heijde D, Landewe R et al. The assessment of SpondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011; 70: 25–31.
- Tsirouki T, Dastiridou A, Symeonidis C et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm 2018; 26: 2–16.
- Karaconji T, Maconochie Z, Mccluskey P. Acute anterior uveitis in Sydney. Ocul Immunol Inflamm 2013; 21: 108–114.
- Haroon M, O'rourke M, Ramasamy P et al. A novel evidence‐based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin uveitis evaluation tool). Ann Rheum Dis 2015; 74: 1990–1995.
- Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis 2008; 67: 955–959.
- D'ambrosio EM, La cava M, Tortorella P et al. Clinical features and complications of the HLA‐B27‐associated acute anterior uveitis: a metanalysis. Semin Ophthalmol 2017; 32: 689–701.
- Sharma SM, Jackson D. Uveitis and spondyloarthropathies. Best Pract Res Clin Rheumatol 2017; 31: 846–862.
- Biggioggero M, Crotti C, Becciolini A et al. The management of acute anterior uveitis complicating spondyloarthritis: present and future. Biomed Res Int 2018; 2018: 9460187.
- Mcallister K, Goodson N, Warburton L et al. Spondyloarthritis: diagnosis and management: summary of NICE guidance. BMJ 2017; 356: j839.
- Arepalli S, Rosenbaum JT. The use of biologics for uveitis associated with spondyloarthritis. Curr Opin Rheumatol 2019; 31: 349–354.